<?xml version="1.0" encoding="UTF-8"?>
<ref id="R94">
 <label>94.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>McLaughlin</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Grillo-Lopez</surname>
    <given-names>AJ</given-names>
   </name>
   <name>
    <surname>Link</surname>
    <given-names>BK</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program</article-title>. 
  <source>
   <italic toggle="yes">J Clin Oncol.</italic>
  </source>
  <year>1998</year>;
  <volume>16</volume>:
  <fpage>2825</fpage>â€“
  <lpage>2833</lpage>.
  <pub-id pub-id-type="pmid">9704735</pub-id>
 </mixed-citation>
</ref>
